Chemical | 30 July 2020
Mitsubishi Chemical to acquire European carbon fiber recycling companies
The acquisition is slated for completion around early August.
The acquisition is slated for completion around early August.
The new business will produce a range of hospital grade hand gels, sanitiser sprays for hands and surfaces and sanitiser wipes, for retail sale, available for the home and to the public.
Acetyl and materials segment impacted the most during the quarter.
The partnership includes the supply of refinish products and color-matching solutions.
The collaboration with D&R Dispersions and Resins offers strategic manufacturing capabilities in Eastern Europe to meet the resin production needs for specialty applications.
The plant is expected to be completely operational by 2024 and is expected to help SABIC reach it's 2025 clean energy target.
Net income rose to Rs 3,246 crore in April-June quarter from Rs 2,800.28 crore in the same period a year ago.
Sales decline 14.55% to Rs 214.95 crore
The company had announced capital expenditure of Rs. 436 crore for the project.
Company anticipates approximately $195 million of cost savings from the restructuring actions in 2020.
On a year-over-year (Y/Y) basis, the barometer fell 8.9 percent in July, ACC said
This initiative aims to reduce the amount of plastic waste entering the environment in the northern Indian cities of Haridwar and Rishikesh.
Volumes stood at 99.0 percent of their average 2012 levels in June.
The total financial outlay of the scheme is Rs. 6,940 crore.
The company sales also declined 27.58% to Rs 51.50 crore in Q1 FY21 as against Rs 71.11 crore last year.
The company posted a net profit of Rs 19.19 crore in Q1 FY21.
Operations from Kaiserslautern, Germany; Wehr, Germany; and Ferrara Marconi, Italy will be relocated to Forli, Italy
The innovation centers feature an improved infrastructure, including an advanced ventilation system for paints and coatings applications as well as state-of-the-art laboratory equipment with a high-end skin analyzer for personal care applications.
DFC has sanctioned $765 million to support launch of Kodak Pharmaceuticals
Manus Bio will use its advanced bio-fermentation platform and industrial manufacturing capabilities to develop a robust production process at the volumes and costs required to enable widespread use as biopesticides.
Subscribe to our newsletter & stay updated.
